Lloyd Dizon Balajadia
About Lloyd Dizon Balajadia
Data last updated:
Lloyd Dizon Balajadia is a Director at Steril-Gene Life Sciences Private Limited (since 2009), Designated Partner at Excipients House Llp (since 2018) and Director at International Ingredients & Excipients Private Limited (since 2019), and holds 3 more current directorships. The companies operate in Pharma, Agriculture and Paper. The 4 current companies with reported revenue have a combined latest revenue of ₹593 Cr; the largest is Steril-Gene Life Sciences Private Limited at ₹404 Cr (FY 2025).
Current companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
 Steril-Gene Life Sciences Private Limited U02423TN2007PTC062549 | Director | 04 Dec 2009 | 2007 | ₹404 Cr (FY 2025) | Active |
 Excipients House Llp AAJ-1683 | Designated Partner | 07 Sep 2018 | 2017 | ₹113 Cr (FY 2024) | Active |
 International Ingredients & Excipients Private Limited U15125TN2017PTC119191 | Director | 01 Jul 2019 | 2017 | ₹41.96 Cr (FY 2025) | Active |
| Lloyd Laboratories Private Limited U24231TN2005PTC057548 | Director | 20 Sep 2005 | 2005 | ₹33.86 Cr (FY 2024) | Active |
| Star-Caps Global Llp ACO-8301 | Partner | 19 Sep 2025 | 2025 | Active | |
| Lloyd Research Centre Private Limited U21002TS2024PTC185417 | Director | 19 Jul 2024 | 2024 | Active |
Board colleagues of Lloyd Dizon Balajadia
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Lloyd Dizon Balajadia
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Lloyd Dizon Balajadia
Lloyd Dizon Balajadia currently holds 6 directorships: Steril-Gene Life Sciences Private Limited (Director, since 04 Dec 2009, revenue ₹404 Cr (FY 2025)); Excipients House Llp (Designated Partner, since 07 Sep 2018, revenue ₹113 Cr (FY 2024)); International Ingredients & Excipients Private Limited (Director, since 01 Jul 2019, revenue ₹41.96 Cr (FY 2025)); Lloyd Laboratories Private Limited (Director, since 20 Sep 2005, revenue ₹33.86 Cr (FY 2024)); Star-Caps Global Llp (Partner, since 19 Sep 2025); and 1 more.
Lloyd Dizon Balajadia was first appointed on 20 Sep 2005 as Director at Lloyd Laboratories Private Limited. The most recent appointment on record is 19 Sep 2025 at Star-Caps Global Llp.
The 4 current companies of Lloyd Dizon Balajadia that report revenue have a combined latest revenue of ₹593 Cr: Steril-Gene Life Sciences Private Limited ₹404 Cr (FY 2025); Excipients House Llp ₹113 Cr (FY 2024); International Ingredients & Excipients Private Limited ₹41.96 Cr (FY 2025); Lloyd Laboratories Private Limited ₹33.86 Cr (FY 2024).
The current boards of Lloyd Dizon Balajadia's companies include Alagappan (Steril-Gene Life Sciences Private Limited), Chanpreet Singh Anand (Steril-Gene Life Sciences Private Limited), Dennis Dizon Balajadia (Steril-Gene Life Sciences Private Limited), Dick Dizon Balajadia (Steril-Gene Life Sciences Private Limited), Manohar Srivignesh (Steril-Gene Life Sciences Private Limited), Maximo Ponce Balajadia (Steril-Gene Life Sciences Private Limited), among others.